Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypes.

MLA

Meyer, S., et al. “Analysis of Genotype 2 and 3 Hepatitis C Virus Variants in Patients Treated with Telaprevir Demonstrates a Consistent Resistance Profile across Genotypes.” Journal of Viral Hepatitis, vol. 20, no. 6, June 2013, pp. 395–403. EBSCOhost, https://doi.org/10.1111/jvh.12046.

APA

Meyer, S., Ghys, A., Foster, G. R., Beumont, M., Baelen, B., Lin, T. ‐I., Dierynck, I., Ceulemans, H., & Picchio, G. (2013). Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypes. Journal of Viral Hepatitis, 20(6), 395–403. https://doi.org/10.1111/jvh.12046

Chicago

Meyer, S., A. Ghys, G. R. Foster, M. Beumont, B. Baelen, T.‐I. Lin, I. Dierynck, H. Ceulemans, and G. Picchio. 2013. “Analysis of Genotype 2 and 3 Hepatitis C Virus Variants in Patients Treated with Telaprevir Demonstrates a Consistent Resistance Profile across Genotypes.” Journal of Viral Hepatitis 20 (6): 395–403. doi:10.1111/jvh.12046.